Frankenius Equity AB 4
4 · TriSalus Life Sciences, Inc. · Filed Dec 19, 2024
Insider Transaction Report
Form 4
Frankenius Equity AB
10% Owner
Transactions
- Purchase
Common Stock
2024-12-17$3.97/sh+62,972$249,999→ 6,230,748 total
Footnotes (1)
- [F1]The shares were issued in connection with the closing of the transaction contemplated by the Securities Purchase Agreement, entered into December 12, 2024, by and between the Issuer and Reporting Person.